Drug Profile
Influenza inactivated virus vaccine quadrivalent - KM Biologics
Alternative Names: KD-FLU (QIV); Quadrivalent inactivated influenza virus vaccine - KM BiologicsLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Kaketsuken
- Developer KM Biologics
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 30 Sep 2019 Discontinued - Phase-II for Influenza virus infections (Prevention, In volunteers, In adults) in Japan (SC)